ORIGINAL RESEARCH

Ethical aspects of phytotherapy

Korotaeva MS, Sidorov AV, Tichonova IG
About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Marina S. Korotaeva
Octyabr avenue, 17D, Yaroslavl, 150040, Russia; ur.relbmar@aveatorokm

About paper

Author contribution: Korotaeva MS — data analysis, manuscript preparation; Sidorov AV — concept of publication, editing; Tichonova IG — data selection.

Received: 2022-10-22 Accepted: 2022-11-24 Published online: 2023-01-30
|
  1. Wills RB, Bone K, Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr Res Rev. 2000; 13 (1): 47–77.
  2. Shih EV, Bulaev VM, Demidova OA. Problemy ocenki bezopasnosti lekarstvennyh rastenij. Bezopasnost’ i risk farmakoterapii. 2015; 2: 23–29. Russian.
  3. Boullata JI, Nace AM. Safety Issues with Herbal Medicine. Pharmacotherapy. 2000; 20 (3): 257–269.
  4. Samylina IA, Bulaev VM. Problemy bezopasnosti lekarstvennyh rastenij, soderzhashchih endogennye toksichnye veshchestva. Farmaciya. 2009; 3: 6–8. Russian.
  5. Barnes J, Anderson L, Phillipson J. Herbal medicines. London, Chicago: Pharmaceutical Press. 2007; 721 p.
  6. Privalova EG, Mirovich VI. Osnovy fitotoksikologii. Obzor rastitel’nyh ob”ektov. Elementy fitohimicheskogo analiza. Irkutsk: IGMU. 2018; 102 s. Russian.
  7. Bulaev VM, Shih EV, Sychev DA. Bezopasnost’ i effektivnost’ lekarstvennyh rastenij. M.: Prakticheskaya medicina. 2013; 272 s. Russian.
  8. SHih EV, Bulaev VM, Demidova OA, Krutikova NM, Sokova EA. Bezopasnost’ primeneniya lekarstvennyh rastitel’nyh preparatov: lekarstvennye rasteniya s gormonal’noj aktivnost’yu. Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya. 2013; 3: 49–52. Russian.
  9. Chadwick LR, Pauli GF, Farnsworth NR. The pharmacology Humulus lupulus L. (hops) with an emphasis of properties. Phytomedicine. 2006; 13: 119–131.
  10. Cos P, De Bruyne T, Apers S, et al. Phytoestrogens: recent developments. Planta Med. 2003; 69 (7): 589–599.
  11. Tutel’yan VA, Belousov YuB, Gurevich KG. Bezopasnost’ i effektivnost’ biologicheski aktivnyh veshchestv rastitel’nogo proiskhozhdeniya. Novosibirsk: EKOR-KNIGA. 2007; 316 s. Russian.
  12. Heyerick A, Vervarcke S, Depypere H, et al. A first prospective, randomized, doubleblind, placebo controlled stady on the use of standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006; 54 (2): 164–175.
  13. Tarlovskaya EI, Koziolova NA, CHesnikova AI. Vliyanie obraza zhizni na effektivnost’ i bezopasnost’ lekarstvennyh preparatov v kardiologicheskoj praktike: chto dolzhen uchityvat’ vrach? Rossijskij kardiologicheskij zhurnal. 2016; 1: 51–59. Russian.
  14. Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol. 2012; 3: 69.
  15. Kirilyuk AA, Petrishche TL. Osobennosti vliyaniya biologicheski aktivnyh veshchestv lekarstvennyh rastenij na farmakologicheskuyu aktivnost’ lekarstvennyh sredstv. Sovremennye problemy zdravoohraneniya i medicinskoj statistiki. 2017; 2. Russian.
  16. Gribakina OG, Kolyvanov GB, Litvin AA, et al. Farmakokineticheskie vzaimodejstviya lekarstvennyh veshchestv, metaboliziruemyh izofermentom citohroma P450 CYP2C9. Farmakokinetika i farmakodinamika. 2016; 1: 21–32. Russian.
  17. Komoroski BJ, Zhang S, Cai H, et al. Induction and inhibition of cytochromes P450 by the St. John’s wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition. 2004; 32 (5): 512–518.
  18. Wang Z, Gorski JC, Hamman MA, et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther. 2001; 70 (4): 317–326.
  19. Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004; 75 (1): 89–100.
  20. Solhaug V, Molden E. Individual variability in clinical effect and tolerability of opioid analgesics — Importance of drug interactions and pharmacogenetics Scandinavian Journal of Pain. 2017; 17 (1): 193–200.
  21. Johne A, Schmider J, Brockmöller J, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John’s wort (Hypericum perforatum). J Clin Psychopharmacol. 2002; 22: 46–54.